5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.67▲ | 1.66▲ | 1.65▲ | 1.58▲ | 1.67▲ |
MA10 | 1.67▲ | 1.65▲ | 1.64▲ | 1.59▲ | 1.57▲ |
MA20 | 1.66▲ | 1.63▲ | 1.62▲ | 1.65▲ | 1.53▲ |
MA50 | 1.63▲ | 1.57▲ | 1.58▲ | 1.60▲ | 1.50▲ |
MA100 | 1.61▲ | 1.59▲ | 1.62▲ | 1.54▲ | 3.89▼ |
MA200 | 1.58▲ | 1.66▲ | 1.63▲ | 1.44▲ | 5.73▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.002▲ | 0.006▲ | -0.001▼ | 0.054▲ |
RSI | 66.070▲ | 63.683▲ | 63.805▲ | 55.227▲ | 51.169▲ |
STOCH | 86.905▲ | 75.893 | 76.458 | 54.909 | 50.298 |
WILL %R | -25.000▲ | -11.111▲ | -7.143▲ | -21.622▲ | -44.068 |
CCI | 159.275▲ | 132.614▲ | 136.134▲ | 90.350 | -12.922 |
Wednesday, August 13, 2025 04:57 AM
US pharma major AbbVie yesterday announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the USA.
|
Wednesday, July 02, 2025 07:07 PM
Published on July 2, 2025 at 10:05 pm by Rameen Kasana in News Actinium Pharmaceuticals, Inc. (NYSE: ATNM) is among the best growth stocks to invest in for the next 5 years.
|
Tuesday, June 10, 2025 01:36 AM
NEW YORK, June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.67 | 1.69 | 1.61 | 1.68 | 100,666 |
14/08/25 | 1.59 | 1.65 | 1.53 | 1.65 | 92,725 |
13/08/25 | 1.53 | 1.64 | 1.49 | 1.60 | 258,200 |
12/08/25 | 1.48 | 1.61 | 1.42 | 1.51 | 301,800 |
11/08/25 | 1.55 | 1.559 | 1.39 | 1.47 | 431,500 |
08/08/25 | 1.57 | 1.60 | 1.51 | 1.54 | 99,200 |
07/08/25 | 1.63 | 1.63 | 1.55 | 1.56 | 65,500 |
06/08/25 | 1.62 | 1.648 | 1.59 | 1.60 | 73,600 |
05/08/25 | 1.64 | 1.66 | 1.605 | 1.62 | 82,800 |
04/08/25 | 1.62 | 1.675 | 1.62 | 1.66 | 88,784 |
|
|
||||
|
|
||||
|
|